Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data

Recently, guidelines for endometrial cancer (EC) were released that guide treatment decisions according to the tumors’ molecular profiles. To date, no real-world data regarding the clinical feasibility of molecular profiling have been released. This retrospective, monocentric study investigated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Oberndorfer, Felicitas, Moling, Sarah, Hagelkruys, Leonie Annika, Grimm, Christoph, Polterauer, Stephan, Sturdza, Alina, Aust, Stefanie, Reinthaller, Alexander, Müllauer, Leonhard, Schwameis, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830511/
https://www.ncbi.nlm.nih.gov/pubmed/33467460
http://dx.doi.org/10.3390/jpm11010048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830511/
https://www.ncbi.nlm.nih.gov/pubmed/33467460
http://dx.doi.org/10.3390/jpm11010048

Ejemplares similares